首页> 外文期刊>Bulletin of experimental biology and medicine >Selective Antitumor Activity of Lymphokine-Activated Killer Cells In Vitro
【24h】

Selective Antitumor Activity of Lymphokine-Activated Killer Cells In Vitro

机译:淋巴因子激活的杀伤细胞的选择性抗肿瘤活性

获取原文
获取原文并翻译 | 示例
           

摘要

We compared cytotoxic activity of blood mononuclear leukocytes from healthy donors and lymphokine-activated killer cells generated from them towards tumor and normal cells. Lymphokine-activated killer cells exhibited higher (in comparison with blood mononuclear leukocytes) killer activity towards tumor cells. Lymphokine-activated cells and mononuclear leukocytes had no lytic effect on non-transformed eukaryotic cells. Hence, we demonstrated selective cytotoxic activity of effector cells (lymphokine-activated killers) towards tumor cells of different origin (but not normal cells).
机译:我们比较了健康供体的血液单核白细胞和由它们产生的淋巴因子激活的杀伤细胞对肿瘤和正常细胞的细胞毒活性。淋巴因子激活的杀伤细胞对肿瘤细胞表现出更高的杀伤活性(与血液单核白细胞相比)。淋巴因子激活的细胞和单核白细胞对未转化的真核细胞没有溶解作用。因此,我们证明了效应细胞(淋巴因子激活的杀手)对不同来源的肿瘤细胞(而非正常细胞)的选择性细胞毒活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号